Posted by Michael Wonder on 20 Dec 2023
Empagliflozin for the treatment of patients with chronic kidney disease
20 December 2023 - NICE has published evidence-based recommendations on the use of empagliflozin (Jardiance) for the treatment of adults with chronic kidney disease.
Empagliflozin is recommended as an option for the treatment of certain adults with chronic kidney disease.
